EBS Competitors & Alternatives

Compare Emergent Biosolutions Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EBS

Main Stock
$7.93
Tradestie Score
54
Market Cap
$490.30M
Revenue Growth
-0.3%
Analyst Upside
+51.3%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AMPH Amphastar Pharmaceuticals, Inc.
$18.12
$1.25B 11.1 54 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$22.32
$1.14B 171.2 48 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$31.06
$1.11B 14.8 57 Compare
CRON Cronos Group Inc. Common Share
$2.71
$1.02B - 59 Compare
VIR Vir Biotechnology, Inc. Common Stock
$8.77
$791.82M - 53 Compare
ESPR Esperion Therapeutics, Inc.
$3.14
$584.71M - 61 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$27.61
$543.32M - 48 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.24
$237.15M 5.3 52 Compare
BIOA BioAge Labs, Inc. Common Stock
$16.04
$212.23M - 56 Compare

Data updated: Jun 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry